COVIDomics: The proteomic and metabolomic signatures of COVID-19
M Costanzo, M Caterino, R Fedele, A Cevenini… - International journal of …, 2022 - mdpi.com
Omics-based technologies have been largely adopted during this unprecedented global
COVID-19 pandemic, allowing the scientific community to perform research on a large scale …
COVID-19 pandemic, allowing the scientific community to perform research on a large scale …
Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
CA Labarrere, GS Kassab - Frontiers in Microbiology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …
Multi-omics for COVID-19: driving development of therapeutics and vaccines
M Guo, M Xiong, J Peng, T Guan, H Su… - National Science …, 2023 - academic.oup.com
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has raised global concern for
public health and economy. The development of therapeutics and vaccines to combat this …
public health and economy. The development of therapeutics and vaccines to combat this …
Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19
COVID-19 continues to affect an unprecedented number of people with the emergence of
new variants posing a serious challenge to global health. There is an expansion of …
new variants posing a serious challenge to global health. There is an expansion of …
Development trends of human organoid‐based COVID‐19 research based on bibliometric analysis
M Li, Y Yuan, T Zou, Z Hou, L Jin, B Wang - Cell Proliferation, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), a global pandemic caused by the severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has posed a catastrophic threat …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has posed a catastrophic threat …
Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
Background Lipids may influence cellular penetrance by viral pathogens and the immune
response that they evoke. We deeply phenotyped the lipidomic response to SARs‐CoV‐2 …
response that they evoke. We deeply phenotyped the lipidomic response to SARs‐CoV‐2 …
New discovery of myeloid-derived suppressor cell's tale on viral infection and COVID-19
Myeloid-derived suppressor cells (MDSCs) are generated under biological stress such as
cancer, inflammatory tissue damage, and viral infection. In recent years, with occurrence of …
cancer, inflammatory tissue damage, and viral infection. In recent years, with occurrence of …
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer
SARS-CoV-2 infection is characterized by several clinical manifestations, ranging from the
absence of symptoms to severe forms that necessitate intensive care treatment. It is known …
absence of symptoms to severe forms that necessitate intensive care treatment. It is known …
Pathogenic mechanism and multi-omics analysis of oral manifestations in COVID-19
M Hao, D Wang, Q Xia, S Kan, L Chang, H Liu… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease that seriously
threatens human life. The clinical manifestations of severe COVID-19 include acute …
threatens human life. The clinical manifestations of severe COVID-19 include acute …
Bioinformatics and molecular biology tools for diagnosis, prevention, treatment and prognosis of COVID-19
DD Meira, ASS Zetum, MC Casotti, DRC da Silva… - Heliyon, 2024 - cell.com
Since December 2019, a new form of Severe Acute Respiratory Syndrome (SARS) has
emerged worldwide, caused by SARS coronavirus 2 (SARS-CoV-2). This disease was …
emerged worldwide, caused by SARS coronavirus 2 (SARS-CoV-2). This disease was …